Sarepta Therapeutics (NASDAQ: SRPT) surges higher on FDA approval for eteplirsen

Letter from FDA

The PDF could not be displayed inside the page, click here to open.

FDA Hot FDA News Management Changes Trader Talk

Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - OppenheimerSeptember 20, 2016 1:18 PM Sarepta Therapeutic (SRPT) PT Raised to $66 at WedbushSeptember 20, 2016 7:21 AM UPDATE: Cowen Upgrades Sarepta Therapeutic (SRPT) to OutperformSeptember 20, 2016 6:41 AM Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/YearSeptember 19, 2016 4:13 PM Jefferies Upgrades Sarepta Therapeutic (SRPT) to HoldSeptember 19, 2016 3:29 PM JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market OutperformSeptember 19, 2016 3:04 PM Sarepta Therapeutic (SRPT) PT Raised to $81 at Needham & CompanySeptember 19, 2016 1:37 PM Sarepta Therapeutics (SRPT) to Hold 4PM ET Investor Call - Bloomberg, Citing PR AgencySeptember 19, 2016 1:37 PM Leerink Partners Upgrades Sarepta Therapeutic (SRPT) to Market PerformSeptember 19, 2016 1:29 PM Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen ApprovalSeptember 19, 2016 1:08 PM SunTrust Upgrades Sarepta Therapeutic (SRPT) to NeutralSeptember 19, 2016 11:43 AM Sarepta Therapeutics (SRPT) Shorts Squeezed After Eteplirsen Receives FDA ApprovalSeptember 19, 2016 11:27 AM Sarepta Therapeutics (SRPT) Pushes to Highs Following FDA Approval; +90%September 19, 2016 11:21 AM Piper Jaffray Upgrades Sarepta Therapeutic (SRPT) to OverweightSeptember 19, 2016 10:58 AM Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to BuySeptember 19, 2016 10:41 AM Sarepta Therapeutic (SRPT) Label More Inclusive Than Anticipated - OppenheimerSeptember 19, 2016 10:40 AM William Blair Upgrades Sarepta Therapeutic (SRPT) to OutperformSeptember 19, 2016 10:35 AM Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen ApprovalSeptember 19, 2016 9:59 AM FDA Approves Sarepta Therapeutics' (SRPT) EteplirsenSeptember 19, 2016 9:52 AM